Chinmay Bhatt appointed Managing Director UK, Ireland & Nordics for Novartis Pharmaceuticals
Jul 29, 2020
London, UK. 20 July 2020 Novartis has announced that, effective 01August 2020, Chinmay Bhatt has been appointed Managing Director UK, Ireland & Nordics for Novartis Pharmaceuticals, following the appointment of Haseeb Ahmad to the global Novartis Pharmaceuticals Executive Committee.
Chinmay joins Novartis UK from Austria, where he successfully led the Novartis Pharma Austria organisation as CPO Head since 2017. He was Vice President and Board member of the Austrian pharmaceutical trade association, PHARMIG. Before this role, he was the Global Head of Strategy for Novartis Pharmaceuticals based in Basel.Prior to Novartis, Chinmay worked at McKinsey and Company for 12 years, where he was one of the lead partners for the European Pharmaceuticals practice. In his new role, Chinmay will be a member of the Novartis European Executive Committee reporting to Janneke van der Kamp.
Haseeb Ahmad will remain Novartis UK Country President and President of the Association of the British Pharmaceutical Industry (ABPI) until April 2021. This will support business continuity as the UK exits the Brexit transition period and will help to support the transition of the country presidency in a phased manner. Haseeb’s new role will see him build a Value & Access and Commercial Development function within the Novartis global team aimed at accelerating the business’ work in increasing access to medicines,as well as product and market shaping for Novartis’ pipeline.
“I feel privileged to be taking this role at such an important time for Novartis UK and the life sciences sector. I would like to thank Haseeb for all his work for Novartis Pharmaceuticals and look forward to building on his successes in the UK, Ireland and Nordics,” commented Chinmay Bhatt, incoming Managing Director UK, Ireland & Nordics for Novartis Pharmaceuticals.
“It has been a huge honour to have worked alongside my Novartis UK colleagues over the past three years. We have gone through a period of unprecedented external events, from Brexit to Coronavirus. At the same time, we have driven a significant and positive cultural change within the UK company to support our associates in our effort to ensure that UK patients get the medicines they need. Throughout this time, I have been continually impressed by the outstanding contributions from every associate. I am proud to be handing over the reins of this brilliant team who work tirelessly to help build a healthier tomorrow to Chinmay. I look forward to continuing to champion speed of access to innovative medicines for UK patients from my new global role,” commented Haseeb Ahmad, Managing Director, UK, Ireland and Nordics, Novartis Pharmaceuticals and Country President, Novartis UK.